• Create account
  • Log in
Clinical Guidelines
  • Home
  • About
    • About the clinical guidelines
    • Declaring and dealing with competing interests
    • Frequently asked questions
    • Guideline journal articles
  • CCA guidelines
    • Barrett's Oesophagus
    • Bowel cancer
      • Colorectal cancer
      • Surveillance colonoscopy
    • Endometrial cancer
    • Cervical cancer screening
    • Lung cancer
      • Lung cancer prevention & diagnosis
      • Lung cancer treatment
    • Prostate cancer
      • Advanced prostate cancer
      • PSA testing
    • Sarcoma
    • Skin cancer
      • Melanoma
      • Keratinocyte cancer (non-melanoma)
    • Pain management
    • Archive of CCA guidelines
  • COSA guidelines
    • Adolescents and Young Adult (AYA) guidelines
      • AYA cancer fertility preservation
      • AYA early cancer detection
      • AYA psychosocial management
    • Cancer therapy medication safety
    • Gastroenteropancreatic neuroendocrine tumours
    • Head & neck cancer nutrition
    • Teleoncology
  • Hosted
    • Childhood Brain Tumour or Leukaemia
  • National Cancer Prevention Policy
  • View
  • View form
  • Code
  • History
  • Refresh
  • What links here
  • Related changes
  • Special pages
  • Permanent link
  • Page information
  • Browse properties

Critical appraisal:Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et al 2011

From Cancer Guidelines Wiki
Jump to:navigation, search
Jutta's exclamation mark icon.png This appraisal is pending.


Article
Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 2011 Dec 17;378(9809):2081-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22036019.
Assigned to
User:Priyashiel.parikh
Topic area
Guidelines:Colorectal cancer/Primary Prevention
Clinical question
  • PPR1: What is the risk-benefit ratio for use of aspirin for prevention of colorectal cancer stratified by risk of colorectal cancer itself? (What is the optimal dose and frequency of administration?)
Form
Form:Quality appraisal rct-cochrane
Outcomes
CRC incidence

Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Critical_appraisal:Burn_J,_Gerdes_AM,_Macrae_F,_Mecklin_JP,_Moeslein_G,_Olschwang_S,_et_al_2011&oldid=120615"
Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.